companydata.dkcompanydata.dk

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S: Financial statements 2017

CVR: 32323502

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S (CVR 32323502) has filed annual accounts for 2017. In 2017, the company reported a gross profit of EUR 257,277 and a net result of EUR -479,755 compared with EUR 3,444,680 the year before. That is a decrease of 92.1% compared with the year before. Equity in the 2017 report amounted to EUR 13,822,655. The solvency ratio was 99.9%.

Gross Profit
EUR 257,277
Profit/Loss
EUR -479,755
Equity
EUR 13,822,655
Total Assets
EUR 13,830,042
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-257K EUR-480K EUR13.8M EUR0
2016-3.2M EUR3.4M EUR14.3M EUR-
2015-5.4M EUR5.6M EUR10.9M EUR-
2014-5.5M EUR5.8M EUR5.3M EUR-
2013-18.5M16.3M19.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S: The 2016 annual report is outMay 11, 2017

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S has published its annual report for 2016. Gross profit came to DKK 3,244,713, and the net result was DKK 3,444,680.

About ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ACP 30.06.2012 1 A/S. The management consists of Jan Møller Mikkelsen. The board consists of Michael Wolff Jensen (chair), Anni Lotte Kirstine Pedersen and Jan Møller Mikkelsen. The company is owned by ASCENDIS PHARMA A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of EUR 5,567,000 and a net result of EUR -5,238,000 compared with EUR 5,001,000 the year before. Equity in the 2025 report amounted to EUR -38,639,000.

Source: annual report 2025, Danish Business Authority